{
  "name": "NHS England Low Priority Treatment - omega-3 fatty acid compounds",
  "title": [
    "Omega-3 fatty acid compounds cost per 1000 patients"
  ],
  "description": [
    "Cost of mega-3 fatty acid compounds per 1000 patients"
  ],
  "why_it_matters": [
    "Omega-3 fatty acid compounds are licensed to treat elevated triglycerides, but evidence of benefit is weak. ",
    "<a href='https://www.nice.org.uk/guidance/cg181/chapter/1-Recommendations'> NICE recommend that they are not prescribed for primary prevention of cardiovascular disease</a>. "
  ],
  "numerator_short": "Omega-3 cost (Â£)",
  "denominator_short": "1000 patients",
  "url": null,
  "is_percentage": false,
  "is_cost_based": false,
  "low_is_good": true,
  "tags": [
    "cardiovascular",
    "efficacy",
    "lowpriority"
  ],
  "numerator_columns": [
    "SUM(actual_cost) AS numerator, "
  ],
  "numerator_from": "{hscic}.normalised_prescribing_standard ",
  "numerator_where": [
    "(bnf_code LIKE '0212000AB%' or bnf_code LIKE '0212000V0%')  "
  ],
  "denominator_columns": [
    "SUM(total_list_size / 1000.0) AS denominator, "
  ],
  "denominator_from": "{hscic}.practice_statistics ",
  "denominator_where": [
    "1 = 1"
  ]
}
